LegalView Re-launched Avandia Information Portal to Assist Victims of Diabetes Drug Complications Including Heart Disease
LegalView refurbished its Avandia practice area to offer insightful resources for victims suffering from Avandia side effects, which may include heart disease and early onset osteoporosis. The drug was approved in mid-1999 and has since created a tidal wave of controversy over its potentially harmful risks.
Avandia, also known as rosiglitazone maleate, is as thiazolidinedione anti-diabetic prescription drug that was introduced to the market in May 1999 from GlaxoSmithKline. Since its release to the public, Avandia has been prescribed to millions of Americans suffering from type 2 diabetes mellitus. However, reports have surfaced recently linking the use of Avandia to severe side effects that may include an increased risk of heart attack as well as an increased risk of bone fractures and early onset osteoporosis. Individuals who are currently taking Avandia or who have taken it in the past and suffer from these or other side effects should contact an experienced Avandia lawyer for legal consultation on developing a potential Avandia lawsuit.
Several studies within the last few years have surfaced, citing the increased risk associated with these side effects including one study conducted by Swiss researchers who used medical records of diabetic patients over a ten-year period. The researchers found that more patients suffered from severe bone fractures and breaks while taking Avandia than compared to those not taking the drug. It is advisable for a patient of this drug to seek out an experienced Avandia law firm where an Avandia attorney can provide sound advice on pharmaceutical litigation.
While the U.S. Food and Drug Administration (FDA) has yet to fully address the alleged Avandia risks with a recall, LegalView continues to offer resources for patients of Avandia affected by the adverse effects of the drug. Additionally, LegalView also provides resources on several other pharmaceutical drugs that have created a stir among in the news for the potential risks; such drugs include Singulair, Chantix and Levaquin.
Singulair is an asthma medication that can also be used to treat severe allergy symptoms. The medication is prescribed to individuals of all ages including children. It was announced in March 2008 that the FDA would be investigating the prescription drug because of increasing reports from patients that the drug was causing strange behavioral changes including suicidal thoughts and tendencies. The Singulair side effects also remain similar to that of the smoking cession drug Chantix. The Chantix risks, which began to surface in November 2007, consisted of those similar to Singulair, including depression, moodiness, erratic behavior and suicidal thoughts and actions.
Levaquin, also known as levofloxacin, is a prescription antibiotic drug used to treat a list of bacterial infections ranging from pneumonia to bronchitis to skin infections. The drug, however, has been under scrutiny because of several studies linking the drug's short- and long-term use to tendon rupture among patients. Individuals who have taken Levaquin and are experiencing Levaquin side effects such as swelling and pain in the muscles, especially calf areas should seek medical attention immediately. Additionally, individuals may wish to discuss potential legal action with an experienced Levaquin attorney.
LegalView.com is a public service brought to you by Legal WebTV Network, LLC, a Limited Liability Corporation created by a group of the nation's most highly respected law firms: Anapol Schwartz; Brent Coon and Associates; Burg Simpson; Cohen, Placitella and Roth; James F. Humphreys and Associates; Lopez McHugh; and Thornton and Naumes. For more information on the accomplishments and track records of LegalView.com's superior sponsoring law firms and to get in touch with LegalView attorneys, visit LegalView at www.LegalView.com/.